Brookfield Corp’s Edwards Lifesciences EW Stock Holding History

Brookfield Corp’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,797	Closed	-$231K	–	640
2023 Q1	$231K	Buy	+2,797	New	+$220K	﹤0.01%	644
2022 Q4	–	Sell	-32,940	Closed	-$2.72M	–	637
2022 Q3	$2.72M	Buy	+32,940	New	+$3.17M	0.01%	392
2022 Q2	–	Sell	-18,241	Closed	-$2.15M	–	644
2022 Q1	$2.15M	Buy	+18,241	New	+$2.05M	0.01%	382
2021 Q3	–	Sell	-28,970	Closed	-$3M	–	551
2021 Q2	$3M	Buy	+28,970	New	+$2.73M	0.01%	289
2020 Q3	–	Sell	-44,738	Closed	-$3.09M	–	403
2020 Q2	$3.09M	Buy	+44,738	New	+$3.18M	0.02%	179

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Brookfield Corp's EW Position: Q2 2023 in Review

Brookfield Corp sold out of Edwards Lifesciences (EW) in Q2 2023, closing a stake of 2,797 shares — an estimated $231K sold.

Brookfield Corp first reported a position in EW in Q2 2020 and held it in 5 quarters. The position peaked at $3.09M in Q2 2020. 1,279 funds tracked by Wall St. Rank hold EW as of Q2 2023.

Brookfield Corp reported no remaining Edwards Lifesciences position as of Q2 2023 after selling out during the quarter.
Brookfield Corp sold 2,797 Edwards Lifesciences shares in Q2 2023, an estimated $231K.
Brookfield Corp first reported a position in Edwards Lifesciences in Q2 2020 and held it in 5 quarters.
Brookfield Corp's Edwards Lifesciences position peaked at $3.09M in Q2 2020.
1,279 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2023.

Based on Brookfield Corp's 13F filing for Q2 2023, filed 14 Aug 2023.